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The occurrence of human immunodeficiency virus type 1 (HIV-1) recombinant genomes belonging to different subtypes is
a common event in regions where more than two subtypes cocirculate. Although there are accumulating data toward an
increase in the number of intersubtype recombinants, little has been addressed about the biological behavior of such mosaic
genomes. This work reports the biological characterization of engineered in vitro HIV-1 intersubtype recombinants in the
gp120 region. The recombinants possess the entire gp120 of B or F Brazilian isolates in the Z6 (subtype D) backbone. Here
we show that this type of recombinant structure results in profound impairment to the establishment of productive infections
in CD4-positive cells. The characterization of biological properties of those recombinant viruses demonstrated viral
production occurring only during a transient peak early on infection and that they are not able to down-regulate the
expression of CD4 receptor on the cell surface. We also report the phenotype reversion of one recombinant virus studied
here, after 62 days in culture. Two amino acid substitutions in highly constant gp120 regions (C1 and C4) were identified in
the revertant virus. The mutation occurring in the C4 region is localized near two amino acid residues critical for gp120/CD4
interaction. Based on these data, we suggest that failure in CD4 down-modulation by recombinant viruses can be due to a
structural dysfunction of gp160 protein unable to block CD4 at the endoplasmic reticule. The possibilities that the
establishment of latent infections can be directly related to the continuous expression of CD4 on the infected cell surface
and that the occurrence of mutations in amino acid nearby residues critical for gp120/CD4 interaction can restore the fully
productive infectious process are discussed. © 2000 Academic Press
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(INTRODUCTION
Among all of the characteristics of human immunode-
ficiency virus type 1 (HIV-1), the most extensively studied
is its growing genetic variability. Nucleotide sequence
analyses of gag and env viral genes, obtained from
nfected patients worldwide, led to a classification sys-
em of these samples based on their phylogenetic rela-
ionships (McCutchan et al., 1992; Myers et al., 1995).
IV-1 strains globally can be classified at least in 10
ifferent subtypes (A–J) of the main (M) group. A number
f sequences exist that differ in more than 50% from the
equences of the M group and from each other, and they
re classified into the group O (“outliner”) (Korber et al.,
997). Finally, highly divergent sequences distinct from
oth M and O groups have been classified as group N
Simon et al., 1998). The relatively low fidelity of viral
everse transcriptase (Mansky and Temin, 1995) com-
ined with the extremely high turnover of virus in vivo
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440109 virions/day) provides the basis for the continuous
mergence of new HIV variants (Ho et al., 1995; Wei et
l., 1995).
Like all retroviruses, each HIV-1 viral particle contains
wo RNA strands of positive polarity. Typically both RNA
trands in a retroviral particle are derived from the same
arent provirus (Artenstein et al., 1995). However, if an
nfected cell simultaneously harbors two different provi-
uses, one RNA transcript from each provirus can be
ncapsidated into a single “heterozygous” virion. For the
everse transcription (RT) process, due to the character-
stics of the virus reverse transcriptase, this enzyme may
ump back and forth between the two RNA templates,
nd as a result the newly synthesized retroviral DNA
equence is a recombinant between the two parental
trands (Hu and Temin, 1990a,b). In fact, interclade HIV-1
ecombinants have been commonly detected in geo-
raphic regions where two or more clades are prevalent
Louwagie et al., 1995). Recombination contributes to the
generation of genetic diversity in HIV-1, and intersubtype
recombinant sequence accounts for more than 10% of all
isolates identified (Burke, 1997; Robertson et al.,
1995a,b). However, not all possible combinations be-
tween HIV-1 strains may give rise to recombinants in
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441INTERSUBTYPE HIV-1 RECOMBINANTS IN env GENEnature, mostly because of viral structural incompatibili-
ties in intermolecular protein interaction (Burke, 1997).
The objective of this work was to study engineered
intersubtype recombinants of HIV-1 in the env gene to
ccess their biological properties and to replicate behav-
or in comparison with their highly replication competent
arental viruses. For this purpose, we manipulated an
IV-1 infectious clone belonging to subtype D by swap-
ing the env gene region by the same genomic region
rom two Brazilian isolates belonging to B and F sub-
ypes. The biological properties and potential of the re-
ombinant viruses to establish productive infections in
IV-1 permissive cells were evaluated.
RESULTS
ecombinant plasmid characterization and cell
ransfections
The replacement of pZ6 gp120 for the same region of
ubtype B or F viral isolates was confirmed by restriction
ap analysis of each construct and by dideoxynucle-
tide sequencing (Fig. 1). Both junction boundaries be-
ween the polymerase chain reaction (PCR) products and
he entire gp120 B or F gene were identical to those
xpected for the procedure, and the nucleotide integrity
f each construct was observed (data not shown). Es-
FIG. 1. Schematic representation of recombinant [pZ6Bgp, pZ6Bgp
genomes.ablished cultures of HeLa cells were transfected with
hose recombinant plasmids and with pZ6 used as con-rol. We observed the same kinetics of viral particle
roduction for all of the recombinants and the parental
nfectious clones (Fig. 2A), indicating the correct assem-
ly of recombinant virions. Moreover, titration of both
arental and recombinant viruses yielded the same
mount of viral particles when assayed by infectious foci
sing MAGI cells (data not shown). We then decided to
haracterize the viral protein pattern produced in HeLa-
ransfected cells. For this purpose, viral particles re-
eased in the supernatant of metabolic 35S-labeled HeLa
cultures were purified by a sucrose cushion and treated
with lysis buffer. The viral proteins were immunoprecipi-
tated with antibody anti-gp120 or anti-HIV-1 (Fig. 2B). As
could be observed, HIV-1 gp120 and gp41 from all viral
constructs were immunoprecipitated when anti-HIV se-
rum was used (Fig. 2B, lanes 3–5). Interestingly, only
gp120 was immunoprecipitated in the chimerical con-
structs when the anti-gp120 antibody was used (Fig. 2B,
lanes 6 and 7), suggesting a weaker interaction between
gp120 and gp41 in these virions compared with that of Z6
(Fig. 2B, lane 8).
Chimeric virus infections in susceptible cells
Viruses harvested from HeLa cell supernatants were
used to infect primary and established lymphocyte cultures.
), pZ6Fgp and pZ6Fgp(vpuZ6)] and parental (pZ6, BR48, BR59) virusPhytohemagglutinin (PHA)-stimulated, interleukin (IL)-2 ac-
tivated peripheral blood mononuclear cells (PBMCs) were
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442 COSTA ET AL.infected with an m.o.i. of 0.1, and the kinetics of virus pro-
duction was monitored every 24 h up to a 1-week period
(Fig. 3). As could be observed, PBMCs infected with B/D or
F/D viral chimeras reached a peak of virus production
within 72 and 48 h after infection, respectively. However,
viral production dropped after the transient peak, and after
7 days, viral particles were barely observed in the super-
natants. Moreover, we noticed that Z6Fgp and
Z6Fgp(vpuZ6) infections, which had reduced virion levels
since the first 24 h after infection, were more severely
impaired than those of Z6Bgp and Z6Bgp(vpuZ6).
FIG. 2. Transfection of HeLa cells with infectious clones and radio-
immunoprecipitation of HIV-1 glycoproteins from supernatants of trans-
fected cells. (A) Monolayers of HeLa cells were transfected with 1 mg
f each plasmid according to the LipofectAMINE protocol (GIBCO BRL).
everal hours after transfection, aliquots of cell supernatants were
ollected and tested for the presence of p24 viral antigen using a
pecific ELISA assay (Coulter-Krefeld, Germany). (B) Transfected cul-
ures were metabolic labeled with 35S-methionine, and the viral parti-
les released at the supernatant were purified by a sucrose cushion.
he purified viruses were treated with lysis buffer, and the viral proteins
ere immunoprecipitated with anti-gp120 antibodies or anti-HIV-1 se-
um. The figure represents the autoradiography of a 12.5% SDS–poly-
crylamide gel. Lanes 1 and 2, anti-gp120 or anti-HIV-1 immunopre-
ipitation of nontransfected cells, respectively. Lanes 3–5, anti-HIV-1
mmunoprecipitation of Z6Bgp, Z6Fgp, and Z6 from the supernatant of
ransfected cells. Lanes 6–8, anti-gp120 immunoprecipitation of Z6Bgp,
6Fgp, and Z6 from the supernatant of transfected cells. The molecular
eight of proteins used as markers is indicated on the left.The inability of recombinant viruses to sustain virus
production was not due to interference in virus binding or
e
Tblocking in virus entry into target cells as it was ob-
served in the p24 uptake assays (Aiken and Trono, 1995).
Normalized amounts of recombinant or parental viruses
were incubated with CEM cells at either 4°C or 37°C.
The p24 uptake in assays carried out at 4°C has dem-
onstrated that recombinant viruses attached to target
cells as efficiently as parental viruses (Fig. 4). We could
also observe, in assays conducted at 37°C, that the entry
process of recombinant viruses was not disturbed and
was quantitatively equivalent to the parental one (Fig. 4).
Although cultures infected by recombinant viruses
could not establish productive infections, they exhibited
an extensive formation of large syncytia in CEMss cul-
tures during the first 7 days of infection (data not shown).
These cells were maintained in culture for up to 14 days.
FIG. 3. Infection of susceptible CD41 cells with parental and recom-
inant viruses. Viruses harvested from HeLa cell supernatants were
sed to infect primary and established lymphocyte CD41 cultures.
PHA-stimulated, IL-2-activated PBMCs were infected with an m.o.i. of
0.1, and the kinetics of viral production was monitored each 24 h up to
a 1-week period using an ELISA-p24 assay. The data are representative
of three independent experiments.
FIG. 4. Evaluation of viral entry into CD41 CEMss cells. Normalized
mounts of recombinant (Z6Bgp or Z6Fgp) or parental (Z6, BR48, or
R59) viruses were incubated with CEMss cells at either 4°C or 37°C
or 3 h. After an extensive washing, the amount of viral particles
ttached to the cell surface (4°C incubation) or inside cell cytoplasm
37°C incubation) was tested using an ELISA-p24 assay. Cells incu-
ated with viruses at 37°C were treated with tripsin before p24 uptake
valuation to remove the particles simply attached to the cell surface.
he data are representative of three independent experiments.
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443INTERSUBTYPE HIV-1 RECOMBINANTS IN env GENEAlthough a great number of large syncytia could be
observed in cultures infected with the parental viruses, in
those infected with recombinant viruses syncytia were
rarely seen (data not shown). We have performed tests of
cell viability in PBMCs and CEMss cultures after 7 and 14
days of infection, and we could notice that recombinant
and parental viruses killed the same amount of cells after
a 7-day period. However, after 14 days of infection, only
25% of cells remained viable in parental virus-infected
cultures, whereas in recombinant virus-infected cultures,
viable cells represented 75% of the total amount (data not
shown). Total amounts of viral DNA inside the infected
cells were determined with quantitative PCR. Using this
technique, we were able to detect the same amount of
viral DNA in cell cultures infected with the recombinant
viruses in all time points (from 24 h up to 14 days)after
infection as we had detected for the Z6-infected cultures
(data not shown).
Because the viral glycoprotein precursor (gp160) is
responsible for the down-regulation of CD4 molecules at
the surface of HIV-1-infected cells (Bour et al., 1995), the
next step was to analyze, 7 and 14 days after infection,
the expression of the CD4 molecules at the surface of
parental or recombinant virus-infected and mock-in-
fected CEMss cells. We could observe that cells infected
with parental viruses progressed to a complete inhibition
FIG. 5. Expression of CD4 molecules at the surface of CEMss cells.
mock infected were double incubated with FITC-conjugated anti-CD4
of CD4 at the cell membranes was determined through analyses in an
at the lower left quadrant express the percentage of CD4-negative ceof the expression of this molecule in the cell surface as
expected for the HIV-1 natural infection course (Bour etal., 1995). On the other hand, cells infected with recom-
binant viruses behaved as the mock-infected culture,
expressing the same amounts of CD4 molecule in their
surfaces during the entire period of infection with no
signs of CD4 down-modulation (Figs. 5A and 5B).
Z6/Z6Fgp coinfection
We have tested the hypothesis that recombinant virus
infection inefficiency might be due to a commitment in
intercellular functions of chimerical gp160. In an attempt
to revert this phenotype, PBMC cultures were coinfected
with Z6 and Z6Fgp viruses at the same time. Fresh
PBMCs were simultaneously challenged by a mixture
containing approximately 1:10 Z6/Z6Fgp viral particles in
a total m.o.i. of 0.1. We noticed in the coinfected culture a
continuous production of viral particles at high levels
throughout the experiment (Fig. 6A). At days 4, 8, 12, 15,
and 18 after infection, the viruses released in the culture
supernatant were harvested and genetically analyzed. To
identify all viruses present, the gp120 gene was RT-PCR
amplified, and the final products were submitted to EcoRI
digestion. Because gp120 sequence from Z6 virus has a
restriction site for this endonuclease that is absent in the
gp120 sequence from Z6Fgp virus, we could distinguish
between the two sequences. Figure 6B shows that at the
nfected with parental (Z6) or recombinant (Z6Bgp or Z6Fgp) viruses or
ti-CD8 antibodies at 7 (A) and 14 (B) days after infection. The amount
can (Becton Dickinson) with CELLQuest software. The values shown
e total amount of cells.Cells i
and anbeginning of coinfection, we could only identify Z6 virus
at the supernatant. As the infection proceeded and
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444 COSTA ET AL.Z6Fgp-infected cells probably became superinfected
with Z6 viruses, we were able to distinguish both viruses
at the supernatant (Fig. 6B, lanes 6 and 7).
The phenotype of recombinant viruses could be
reverted during the time of PBMC infection
Cultures of PBMCs infected with recombinant and
parental viruses were maintained up to 60 days after
infection, and at each 4-day interval, viral particle
amounts at the supernatant were evaluated. We ob-
served that viral production in recombinant virus-infected
cells were very low after the first week of infection.
However, in the supernatant of Z6Bgp-infected PBMCs, a
FIG. 6. Coinfection of PBMCs with recombinant (Z6Fgp) and parental
(Z6) viruses. PBMCs were infected with a mixture of Z6Fgp and Z6 viral
stocks at a rate of 10:1, respectively. (A) Several days after infection, the
amount of virus release at cell supernatants was determined by an
ELISA-p24 assay and compared with that of singly infected cultures. (B)
The presence of each virus at the supernatant of double-infected
culture was distinguished after EcoRI digestion of previously RT-PCR-
amplified gp120 DNA fragments, because this sequence derived from
the Z6 virus possesses an EcoRI restriction site that is absent in the
equence derived from the Z6Fgp virus. At 4, 8, 12, 15, and 20 days (D4,
8, D12, D15, and D20), an aliquot of the culture supernatant was
ollected and processed for RT-PCR amplification. MW indicates mo-
ecular weight marker fX174/HaeIII (GIBCO BRL).burst in viral production was observed after 62 days
postinfection. From this moment, the infectious process
i
pbecame highly productive, which suggested a spontane-
ous reversion of the Z6Bgp initial phenotype. In conse-
quence, we searched for some mutations taking place at
the env region that could account for this change in
phenotype. We obtained the entire sequence of the env
(gp120 and gp41 including nef gene) and p17 region from
iruses present at each 4-day interval of PBMC culture
hrough direct sequencing of PCR products. We identi-
ied, through sequence analyses of the revertant virus
ompared with that of the Z6Bgp, two amino acid sub-
titutions in highly conserved regions of the gp120: a
ethionine-to-isoleucine substitution (M104I) in the C1
egion and a glutamic acid-to-lysine substitution (E434K)
n the C4 region (Fig. 7). We also looked at the amino acid
equences from the previous time points, and those
equences were equivalent to that of the Z6Bgp virus
resent at the beginning of infection. Finally, sequencing
f the gp41 genes at all time points did not provide
vidence of any changes in that gene (data not shown).
DISCUSSION
Given the high frequency of intersubtype recombinant
IV-1 strains being documented (Korber et al., 1997), the
ain goal of this work was to access the in vitro biolog-
cal behavior of mosaic viruses to look for ways of im-
roving fitness. Because the envelope region of HIV-1
lays important roles in biological and immunological
spects of virus replication (Cann et al., 1992; Cao et al.,
993, 1996; Carrilo and Ratner, 1996; Cheng-Mayer et al.,
988; Stamatatos and Cheng-Mayer, 1993), we attempted
o construct the recombinant viruses within such region.
he pZ6 infectious clone was successfully manipulated,
nd we obtained two types of recombinant constructs.
he first set of recombinant viruses (Z6Bgp and Z6Fgp)
ossesses the entire gp120 region from B or F viral
solates, respectively, replacing the correspondent gene
nto the Z6 backbone. It has been reported that Vpu plays
wo crucial functions in HIV-1 life cycle: enhancement of
irus release from infected cells and degradation of CD4/
p160 complexes at the endoplasmaic reticulum (RE)
Bour et al., 1995, 1996; Bour and Strebel, 1996; Cuc-
hirini et al., 1995; Ewart et al., 1996; Fujita et al., 1996;
wanati et al., 1997; Klimkait et al., 1990). Due to this, the
econd group of viruses [Z6Bgp(vpuZ6) and
6Fgp(vpuZ6)] were generated by replacing the Z6
p120-env with the correspondent region from the B or F
solates but with an intact ORF of Vpu protein, which
verlaps at the beginning of gp120. HeLa cells trans-
ected with all mosaic viruses released great amounts of
irions, and the number of infectious particles measured
y MAGI assay was the same as that of Z6 (Fig. 2 and
ata not shown). These results indicated that substitu-
ion of gp120 region in the Z6 infectious clone does not
mpose constrains to the formation of HIV-1 infectious
articles in CD4-negative cell systems. Moreover, pro-
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445INTERSUBTYPE HIV-1 RECOMBINANTS IN env GENEtein pattern analysis of viral particles through immuno-
precipitation with anti-HIV sera revealed the presence of
both envelope glycoproteins gp120 and gp41 (Fig. 2B).
Processing, glycosylation, and transporting of viral gly-
coprotein precursors throughout the cellular secretion
pathway are indicative of the correct folding of such
glycoproteins (Doms et al., 1993; Willey and Strebel,
FIG. 7. Amino acid alignment of gp120 region of Z6, Z6Bgp, and the Z6
the Z6Bgp revertant virus). Sequences are numbered according to the Z
represent similarity). Positions where mutations were found in the rev
regions are indicated at the top. Amino acid residues critical for gp121996; Willey et al., 1988, 1991). The HIV-1 gp160 precursor
folding is a function of interactions between the gp120-
i
wand gp41-related regions (Earl et al., 1990; Gelderblom et
al., 1987; Hunter, 1997; Leonard et al., 1990; Otteken et
l.,1996). The visualization of a normal protein pattern
rom the viral particles and the release of infectious
articles from transfected cells confirm the efficiency of
uch processes even with the recombinant envelope.
Immunoprecipitation of gp41 using anti-gp120 antibod-
ertant viruses. Sequence names are shown on left (Z6Bgprev indicates
ence, and only changes relative to Z6 are shown in the alignment (dots
virus are marked by asterisks. gp120 variable (V) and conserved (C)
ng to CD4 are in bold.Bgp rev
6 seques was not observed for the recombinant viruses as it
as for the Z6 (Fig. 3, compare lane 6 or 7 with lane 8).
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446 COSTA ET AL.This could be indicative of a weaker interaction between
B- and F-related gp120 with the Z6 gp41 protein. It has
been demonstrated that there is a decrease in viral
infectivity for some HIV-1 isolates due to a loss of the
gp120 surface glycoprotein (Gelderblom et al., 1995;
ckcating et al., 1991; Siciliano et al., 1996). The weaker
nteraction described could represent an increase in
hedding of the gp120 from the viral surface. However, it
oes not seems to have consequences for the viral
article formation in CD4-negative cells. The conforma-
ional status of the interacting gp120/gp41 in viral enve-
ope affects the virus binding to the host cell receptor
nd the postbinding processes such as membrane fu-
ion and virus entry (Bour et al., 1995; Carrilo and Ratner,
996; Helseth et al., 1991; James et al.,1996; Moore et
l.,1994; Stamatatos and Cheng-Mayer, 1993; Wang et al.,
995; Wyatt and Sodroski, 1998). However, such recom-
inant viruses were perfectly able to enter CD4-positive
ell lines (Fig. 4), indicating that a structural conformation
f gp120 and gp41 proteins that allows the CD4 binding
nd viral entry was achieved.
Our results demonstrated that recombinant viruses
ehaved differently from parental viruses regarding the
stablishment of infections in CD4-positive cells. We
bserved a peak of virus production early in infection of
ecombinant viruses that dropped and established at
ery low levels (Fig. 3). The fact that recombinant viruses
ill the same amount of cells at the early stage of infec-
ion as well as the parental viruses negates the idea that
iral production could not be sustained due to massive
ell death. Furthermore, viral DNA could be measured in
ecombinant virus-infected cells during all infectious pe-
iods, indicating that cells present in culture had been
nfected. The lack of virus release was not related to an
nhibition of viral protein synthesis for at least 7 days
fter infection because the same levels of p24 expres-
ion in parental and recombinant Z6 virus-infected cells
ere detected. This is corroborated by the observation of
noteworthy cytopathic effect with formation of large
yncytia at the seventh day of infection. Taking all of
hese characteristics together, we suggest that recombi-
ant viruses are not able to sustain a productive infection
n CD4-positive cells. The absence of virus release de-
pite of viral structural protein expression could be re-
ated to a nonfunctional Vpu protein (Bour et al., 1995,
996; Bour and Strebel, 1996; Cucchirini et al., 1995;
wart et al., 1996; Fujita et al., 1996; Iwanati et al., 1997;
limkait et al., 1990). The fact that Z6Bgp(vpuZ6) and
6Fgp(vpuZ6) viruses have similar infectious character-
stics of Z6Bgp and Z6Fgp viruses, which preserve the
ild Vpu reading frame, rules out this possibility.
It is well established that the HIV-1 glycoprotein pre-
ursor gp160 has as important function during infection:
he down-regulation of the viral receptor molecule CD4
Bour et al., 1991, 1995; Martin and Nayak, 1996c; Steven-
on et al., 1988). The major route responsible for thenhibition of expression of this molecule at the surface of
nfected HIV-1 cells is the binding of gp160 with CD4
uring their syntheses in the endoplasmic reticulum
Crise and Rose, 1992; Crise et al., 1990). The conserved
mino acid residues critical for the extracellular gp120/
D4 attachment are also essential to gp160/CD4 inter-
ction in the endoplasmic reticulum, but the achieve-
ent of a proper structural conformation seems to be
ritical for the intracellular binding of gp160 to CD4. It
as been demonstrated that this proper conformation is
function of a correct interaction between gp120 and
p41 subunits within the gp160 precursor (Martin and
ayak, 1996a,b). The results presented here demon-
trate that cells infected with recombinant viruses were
ot able to down-regulate CD4 expression in the cell
urface compared with those infected with Z6 (Fig. 5).
hus the inefficiency of CD4 down-modulation in recom-
inant virus-infected cultures at 1 week postinfection
robably could be accounted for by a blockage in the
ormal CD4/gp160 interaction.
Some hypotheses that attempt to correlate the block-
ge of CD4 down-regulation and the failure in establish-
ent of productive infections were previously proposed.
arshal et al. (1992) demonstrated that a CD4 cell clone
xpressing 10% more CD4 molecules than the original
ell line at the cell surface blocked HIV-1 viral replication
t a postintegration stage. [Other enveloped viruses,
uch as influenza and coranaviruses, similarly devel-
ped a strategy of receptor down-modulation for efficient
iral release (Palese et al., 1974; Vlasak et al., 1988).]
oreover, there are additional data demonstrating a
traight correlation between high levels of CD4 expres-
ion at the infected cell surface and a failure to establish
roductive infection (Butera et al., 1994). The simian
mmunodeficiency virus isolate SIVagm is able to produce
a stable infection in a low CD4-expressing cell line
(Hut-78) but not in a high CD4-expressing cell line such
as Sup-T1 (Hoxie et al., 1988). Thus the differences in
viral production between our chimerical viruses and the
parental Z6 observed here could be accounted for by the
fact that chimerical viruses are not able to down-regulate
the CD4 receptor, consequently blocking virus release.
In fact, this idea is supported by our coinfection experi-
ment. In this case, the production of the Z6Fgp infection
was allowed by coinfection of Z6Fgp nonproductively
infected cells with Z6 parental virus. The trans-comple-
mentation experiment suggested that the lost intracellu-
lar function of our recombinant viruses could result from
a defective gp160 chimerical protein that is comple-
mented by the wild-type form, leading to the increase in
viral production.
The spontaneous reversion of Z6Bgp phenotype after
62 days of infection highlights some aspects of recom-
binant virus infections. First, the occurrence of amino
acid changes in the new virus demonstrate that although
there is a lack of virus production, cells present in culture
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447INTERSUBTYPE HIV-1 RECOMBINANTS IN env GENEwere infected and had continuously undergone some
cycles of virus replication and that mutations in con-
served regions of gp120 (C1 and C4) could be indicative
of selective pressure acting in this molecule. Second, the
fact that amino acid changes involved a nonconservative
mutation (lysine for glutamic acid, an amino acid residue
that occurs in high frequencies at this site) within a
region critical for gp120 binding to CD4 molecule
strongly suggests that this mutation is a compensatory
mutation for Z6Bgp recombinant. A nonconservative mu-
tation (E434K) occurring at the C4 region very close to
two amino acid residues (W/D432 and V435) that are
fundamental to CD4 binding can account for the new
phenotype, probably by promoting the correct function of
gp160 precursor inside the endoplasmic reticulum. In
fact, it has already been demonstrated that amino acid
residues critical for the binding of gp120 to CD4 at the
cell surface are also required for intracellular binding of
gp160 to CD4; moreover, it appears that gp41 sequence
may influence the way in which gp120 binds to CD4
(Martin and Nayak, 1996a,b). However, no mutations
were found in gp41 or in other genomic regions of Z6Bgp,
like nef and p17. Thus the impairment of chimerical
gp160 to bind CD4 intracellularly can be a consequence
of inadequate gp120/gp41 conformation, masking the
correct amino acid residues important for this attach-
ment. Wang et al. (1996) demonstrated the importance of
single mutations in C1 and C4 regions that account for
phenotype reversion of HIV-1 isolates impaired with CD4
binding, suggesting a change in functional interactions
as the consequence of these compensatory mutations.
Structural impairments between the gp120 and gp41
molecules can thus have a profound impact on gp120
functions (deMareuil et al., 1995, 1992; Helsethe et al.,
1991, 1992). We suggest here that gp160-CD4 down-
modulation is an important event in the establishment of
productive infections in CD4-positive infected cells. Nev-
ertheless, this selective pressure could exist to preserve
the correct gp120/gp41 interactions. Thus recombination
in HIV genomes within this region, bringing together
interacting molecules with diverse genetic identities, will
be successful only if these molecules can interact prop-
erly.
MATERIALS AND METHODS
Cells
HeLa cell lines were maintained as monolayer cul-
tures in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% FBS, penicillin/streptomycin
[(P/S) 500 U/500 mg/ml], and 2 mM L-glutamine at 37°C
with 5% CO2. Another HeLa cell line, termed HeLa MAGI,
as maintained as described but the medium was com-
lemented with hygromicin B (0.1 mg/ml) and G418 (0.15
g/ml) antibiotics (Kimpton and Emerman, 1992).
CEM, Hut-78, and MT-2 cells were maintained as sus-ension cultures in RPMI 1640 medium supplemented
ith 10% FBS, P/S (5000 U/10 mg%), and 2 mM L-glu-
tamine. PBMCs were isolated from the whole blood of
healthy donors using the Phycol-Hypaque density sepa-
ration medium (Organon Teknika, Netherlands) and cen-
trifugation. The PBMCs were then stimulated with 1
mg/ml PHA and cultured in RPMI 1640 medium supple-
mented with 10% FBS, P/S (500 U/500 mg/ml), and 2 mM
L-glutamine for 3 days, before culture infections. At the
oment of use, the medium was replaced by a medium
ontaining 20 U/ml recombinant IL-2.
irus
Brazilian viral isolates used in this study had been
reviously characterized (Ramos et al., 1999.). BR48 iso-
ate was subtyped as B in both gag and env genes,
whereas BR59 isolate were subtyped as F in both
genomic regions. Also, those isolates were both charac-
terized for coreceptor use as R5 and X4 dual tropic
viruses and showed a syncytia-inducing (SI) phenotype
in CEMss cell cultures (data not shown). Culture super-
natants were analyzed for virus production by ELISA-p24
specific assays (Coulter, Krefeld, Germany), and the in-
fected cell-free supernatants were stored at 270°C. To
obtain DNA samples for further PCR amplification reac-
tions, infected cells were treated with the Tris–Triton–
PTK lysis buffer and incubated at 65°C for 1 h after PTK
inactivation for 10 min at 95°C (Pianiazek et al., 1991).
Lysates were stored at 270°C.
Plasmids, cloning strategies, and sequencing
pZ6, a pBR322 containing the full-length genome of a
clade D HIV-1 isolate (Srinivasan et al., 1987), was used
to generate the chimeras. PCR-amplified gp120 env frag-
ments from Br48 or Br59 isolates were cloned into pCRII
(TA Cloning Kit Vector; InVitrogen, San Diego, CA). The
clones were further used as donors of the regions to be
replaced in the infectious clone pZ6. The strategy to
obtain the chimeric infectious clones used PCR amplifi-
cation of both vector backbone without the region to be
replaced and the env region from the donor DNAs. Prim-
ers that were used contain a type II endonuclease site,
Eam1104I, to generate, after enzymatic digestion of the
amplified product, a complementary tail at the 59 and 39
ends of insert and vector fragments, which on further
treatment with T4 ligase can reconstitute an entire mol-
ecule (Padgett and Sorge, 1996). The PCR conditions for
insert and vector amplifications basically followed the
standard protocol (Seamless Cloning Kit; Stratagene, La
Jolla, CA). All PCRs were performed in presence of mod-
ified dCTP-methyl dideoxynucleotide to protect from di-
gestion the internal Eam1104I sites that could exit those
molecules. The primers used to substitute the entire
gp120 gene are depicted in Table 1. PCR products were
then purified using Qiagen QUIAquick Spin Kit (Qiagen,
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448 COSTA ET AL.Hilden, Germany) according to the manufacturer’s spec-
ifications. Related purified products were combined in
the same reaction tube, with a fivefold excess of insert
compared with the vector, in the presence of T4 DNA
ligase and endonuclease Eam1104I according to the
protocol. The reaction was incubated at 37°C for 1 h.
One tenth of the ligation reaction was then used to
transform the XL1-Blue MRF9 supercompetent bacteria
upplied with the kit. A schematic representation of all
onstructs is shown in Fig. 1.
Sequencing of plasmids or PCR products was per-
ormed with a dye-labeled dideoxynucleotide mix (ABI
RISM Dye Terminator Cycle Sequencing Ready Reac-
ion Kit; Applied Biosystems, Foster City, CA) and run in
n ABI 373 automated sequencer.
ammalian cell transfections
To obtain infectious viral particles from the chimeric
lones, HeLa cells were transfected with the Lipo-
ectAMINE cationic liposome-complexed plasmids
GIBCO BRL, Gaithersburg, MD). Briefly, 2 3 105 cells
ere seeded onto each well of 6-well plate 18 h before
ransfection and maintained as previously described.
ne microgram of each plasmid was combined with 10
ml of the liposome solution in 500 ml of medium 30 min
efore addition to the cells. Cells were incubated with
he DNA–liposome complexes at 37°C for 5 h, fresh
edium was added to a total volume of 2 ml, and cells
ere incubated at 37°C overnight. On the next day, the
T
Primers Used in
Primer Position in Z6 clone Se
gp120F 6227–6251 AGT
GAGTG
p120R 7753–7732 AGT
CTTTT
Vector 120F 7749–7773 AGT
AATAGG
ector 120R 6231–6207 AGT
TTGCC
gp120(2vpu)Fb 6562–6587 AGT
GCCTAA
Vector 120(1vpu)Rb 6567–6543 AGT
GATCCC
a The underlined nucleotides represent the recognition site for Eam
nds generated after enzymatic digestion of PCR amplified products. T
rimer end, in the same way as the insert reverse primer end and the
b To substitute the gp120 gene in the pZ6 without changing the se
combination with the reverse already described and another reverse p
insert and the vector, respectively.edium was replaced by fresh medium containing FBS,
nd aliquots from the supernatants were harvested forach 24-h period and analyzed for the presence of viral
articles using the ELISA-p24 assay (Coulter, Krefeld,
ermany). Supernatants harvested from transfected
ells at the peak of viral production were clarified from
ell debris by centrifugation at 10,000 3 g for 1 h, and
-ml aliquots were stored at 270°C. Each frozen aliquot
as thawed only once before use.
rotein labeling and radioimmunoprecipitation
HeLa-transfected cells were starved for 1 h in methi-
nine–cysteine-free medium before being labeled for
2 h in medium containing 350 mCi of 35S-methionine-
cysteine (TransLabel System; ICN, Costa Mesa, CA). At
the end of the radioactive labeling period, the superna-
tants were collected and layered on a 60% sucrose
cushion, and the viral particles were pelleted at 35,000
rpm for 2 h. Radioimmunoprecipitation assays (RIPAs)
were performed as described elsewhere. Briefly, the pel-
lets were resuspended in 1.5 ml of RIPA buffer (150 mM
NaCl, 100 mM Tris–HCl, pH 7.5, 5 mM EDTA, 1% NaDOC,
1% Triton X-100, 1% SDS, 10 mg/ml aprotinin, 2 mg/ml
leupeptin, 2 mg/ml benzamidin, 10 mg/ml TLCK, and 0.2
M PMSF) and incubated on ice for 15 min. Five hun-
red microliters were incubated with 5 ml of an anti-HIV
serum or with 5 ml of anti-gp120 or anti-gp41 antibodies
vernight at 4°C. Then, 5 ml of a Staphylococcus aureus
protein A-Sepharose suspension was added, and the
mixture was incubated for 2 h at 4°C. The immunocom-
plexes were washed three times with RIPA buffer, sus-
6 Manipulation
e (59 to 39)a Region replaced
CTTCA TGA
GATAGAGAGGA
gp120 amplification of donor sequence
CTTC T GCT
TTTCCACCACT
CTTC G AGC
GGAGCTATTGTT
Vector amplification but gp120 region
CTTC C TCA
CTTCTGCTCTT
CTTC C AAA gp120 amplification of the donor but Vpu
ATGTGTTAAAAT
CTTC C TTT Vector amplification but gp120 region
ACTGATTATAT (keeping Z6 Vpu)
ndonuclease, and the bold nucleotides represent the complementary
rt forward primer end is reverse complementary to the vector reverse
forward primer end.
alf of Vpu coding sequence that overlaps, another forward primer in
combination with the forward previously described were used for theABLE 1
the pZ
quenc
TA CT
AGGGG
TA CT
TTCTC
TA CT
ACTA
TA CT
ACTGT
TA CT
AACC
TA CT
ATAA
1104I e
he inse
vector
cond hpended in reducing sample buffer, and boiled for 5 min
before loaded in a 4% stacking/12.5% separating SDS–
H
p
v
449INTERSUBTYPE HIV-1 RECOMBINANTS IN env GENEpolyacrylamide gel. Gels were dried and subjected to
autoradiography.
Virus titration
Virus titration assays were preformed in MAGI cells as
previously described (Kimpton and Emerman, 1992).
Briefly, supernatants of transfected cells, previously mon-
itored for the presence of viral particles by ELISA-p24
assay (Coulter), were used for serial dilutions in DMEM,
and those dilutions were layered on CD4-LTR/b-gal
eLa (MAGI) cell monolayers (at 20% confluence) in the
resence of 20 mg/ml DEAE-dextran. Cells were culti-
vated in DMEM with 10% FBS for 2 days. Cells were then
fixed and stained with X-Gal according to the standard
protocol (Kimpton and Emerman, 1992). Blue cells were
counted under a microscope at a magnification of 1003.
PBMCs and established lymphocyte infections
After 3 days in the presence of PHA stimulation, 1 3
107 PBMCs were pelleted and resuspended in a 2-ml
olume of RPMI 1640 with 1 3 105 TCID50 viral particles
(m.o.i. 5 0.1). After 3 h of viral absorption at 37°C, the
medium was removed, the cells were washed twice with
PBS suspended in a 1–0ml volume of RPMI 1640 con-
taining 10% FBS and 20 U/ml IL-2, and incubated at 37°C.
For every 4-day period, half of the cell culture volume
was taken and processed for supernatant and cell lysate
evaluation and storage. The same volumes of healthy
PHA-stimulated PBMCs in a medium with 20 U/ml IL-2
were added to the cultures.
CEMss and Hut-78 cells were infected at 37°C at an
m.o.i. of 0.1, with a 3-h absorption period. Next, the me-
dium was removed, and the cells were washed twice
with PBS and suspended in RPMI 1640 medium with 10%
FBS. Infected cells were evaluated daily under a micro-
scope to observe the cytophathic effects.
Virus entry assays
To evaluate the virus efficiency for CD4 absorption and
entry, a suspension of CEMss cells was incubated for 3 h
with a minimum volume of RPMI 1640 medium contain-
ing viral particles at an m.o.i. of 1 at both 4°C and 37°C.
The former temperature allows virus binding to the cell
surface CD4, whereas the letter temperature allows both
binding to CD4 and virus entry into the cell cytoplasm.
After the absorption period, the cells were washed with
PBS, and the cells infected at 4°C were directly sus-
pended in the ELISA lysis buffer (Aiken and Trono, 1995).
As a control, samples were also assayed at 4°C, fol-
lowed by trypsin treatment before lysis and ELISA-p24
detection. Cells infected at 37°C were suspended in a
PBS–0.5 M EDTA solution containing 0.25% of trypsin and
incubated for 30 min at 37°C to eliminate virus particles
that were bound to the cell surface. Then cells were
pelleted and directly suspended in the ELISA lysis buffer.All lysates were used for viral particle detection by
ELISA-p24-specific assays (Coulter).
PCRs
Lysates from infected cultures were used in nested
PCRs for env amplification. Reactions were performed as
described elsewhere. Primers used for env amplification
were outer ED3/ED14 and inner ED5/ED12 (Delwart et
al., 1994). Quantitative PCRs were performed using DNA
limiting dilution protocol as previously described (Sim-
monds et al., 1990). The supernatant of infected cells was
used for viral RNA extraction with the QIAamp RNA
Extraction Kit (Qiagen). RNAs were then used as tem-
plates for MuLV RT-PCRs. The procedure was performed
as described in the GeneAmp RNA PCR Kit Protocol
(Perkin–Elmer Cetus, Norwalk, CT).
Cell surface CD4 expression analysis
Expression of CD4 in the surface of CEMss cells was
evaluated by FACS analysis. Briefly, 2 3 106 infected or
mock-infected cells were incubated in the dark with
FITC-conjugated anti-CD4 monoclonal antibodies for 30
min at room temperature. After that, cells were washed
with PBS containing 2% human serum, 00.2% sodium
azide, and 0.1% BSA. Cells were fixed overnight in 1%
formaldehyde before FACS analysis in a Becton Dickin-
son FACSscan with CELLQuest software (San Jose, CA).
Samples were taken of cells from infected cultures
and used to confirm the presence of viral DNA by quan-
titative PCR. Results demonstrated for all infected cul-
tures (Z6, Z6Bgp, and Z6Fgp) that each cell in the in-
fected population harbored viral DNA, confirming that
cells analyzed by FACS had been previously infected.
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